Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Evaluation of Population Frequency Data For Mitochondrial Variant Interpretation

ACMG 2023, Annual Clinical Genetics Meeting

American College of Medicine Genetics

Salt Lake City, UT, March 14-18, 2023

Poster presentation: Evaluation of population frequency data for mitochondrial variant interpretation

Authors: Maston G, von Nandelstadh P, Tuupanen S, Karbassi I, Koskenvuo J

Specialties: Genetics

Related content

Conference Presentation
Searching beyond exons in nuclear genes: Diagnostic deep intronic and mitochondrial DNA variants in patients with monogenic diabetes
Conference Presentation
Small CNVs, noncoding, and mitochondrial variants are molecularly diagnostic for 4.7% of pediatric patients with inherited retinal disease
Conference Presentation
Increasing diagnostic yield of panel-based testing: retrospective review mitochondrial genome analysis

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.